adherence.

Integrating the #MMAS Platform into your clinical practice is not just a smart choice—it's a proven strategy for improving patient care. Studies have shown that nurse-led and pharmacist-led interventions significantly enhance medication adherence, which directly correlates with better health outcomes. The MMAS Platform equips your team with an evidence-based tool to identify patients at risk for non-adherence through eight simple questions, allowing for timely and targeted interventions. By using MMAS, your nurses and pharmacists can be that catalyst in ensuring patients stay on track with their treatment plans. The impact of improved adherence is undeniable: when patients consistently follow their prescribed regimens, they experience fewer complications, reduced hospitalizations, and overall better health. With the MMAS Platform integrated into your practice, you'll tap into the power of evidence-based practice to drive these outcomes. This is about elevating the standard of care you provide; providing your team with tools that make a real difference.

Somewhere in the world, right now, the Morisky Medication Adherence Scale (#MMAS) is being administered—every minute, every hour, seven days a week. Through clinical trials, research studies, and standards of care practices, MMAS is shaping the future of healthcare. Its reach extends globally, embedded in EHR systems, remote patient monitoring, and partnerships that drive better outcomes. This simple, validated tool is more than a questionnaire—it’s a bridge between patients and providers, unlocking insights and improving lives. With ATLAS ? shaping the future of predictive analytics, taking empirical data and combining it with real time insights, data rich is more than just a buzz word. ?? What an incredible testament to the power of innovation and collaboration in healthcare! Follow adherence. for an exciting update that will make 2025 a milestone year!

Gratitude with Attitude: Happy Thanksgiving from Adherence! This Thanksgiving, we reflect on the privilege of serving millions of people around the world in their journeys to better health. Through tools like the MMAS, and now with ATLAS ? and its predictive analytics, we’re helping to transform medication adherence from a challenge into an achievable goal. Every dose remembered, every barrier overcome, every life improved—this is what fuels our passion. We’re grateful for our incredible partners, collaborators, and supporters who share our mission to make healthcare more effective and patient-centered. Here’s to progress, purpose, and people—the heart of everything we do. Thank you for trusting us to make a difference. Together, the future of adherence is brighter than ever. Wishing you all a healthy, joyful, and gratitude-filled Thanksgiving! #Thanksgiving #GratitudeWithAttitude #MedicationAdherence #MMAS #ATLAS #Innovation

??Scaling Adherence and Value-Based Care Through Innovation?? ??As healthcare shifts toward value-based care, improving patient outcomes is becoming the central focus for stakeholders. Tools like the Morisky Medication Adherence Scale (MMAS) are crucial in this journey, helping providers and pharmacies identify barriers to adherence and deliver personalized interventions. ????????With more healthcare systems and EHRs onboarding MMAS protocols into their workflows, we’re generating invaluable Real-World Evidence that feeds into our predictive analytics platform, ATLAS ?. This integration not only streamlines adherence assessments but also enhances our ability to predict patient behaviors, optimize care plans, and deliver actionable insights at scale.???? ??PBMs are evolving to prioritize long-term benefits of therapies, and retail pharmacies are redefining their roles by contributing directly to improved outcomes through adherence programs and Medication Therapy Management.?? How is your organization leveraging data and predictive analytics to advance value-based care? Article from Pharmacy Times by Muhammad Cheema, PharmD in comments.

?? ?????????????? ???? ?????????? ?? ?????????????????????? ?????????????????? ???? ???? ???????????????? ??????????????! ?? I am honored to have been granted the MMAS-8 license under the Adherence's Student/Researcher Initiative, which fosters collaborative partnerships between universities and the organization. This opportunity was made possible through the support of my university, endorsed by Asaad Nafees, Program Director of MSPH at Aga Khan University, and the thoughtful guidance of Philip Morisky, MBA, Ξ This initiative connects academic researchers with resources to advance impactful research. As part of this program, I have been granted access to the Morisky Medication Adherence Scale (MMAS-8) at no cost—an incredible gesture that reflects a commitment to empowering students and researchers. The MMAS-8 is a globally recognized, reliable, and comprehensive tool for assessing medication adherence. In my thesis, titled "?????????????? ?????????????????????? ???????????????????????? ?????????????????? ?????????? ???????????? ???????????? ????????????????: ?? ??????????-?????????????????? ?????????? ???? ??????????????, ????????????????,"?I will utilize the MMAS-8 to uncover critical insights into breast cancer patient's chemotherapy adherence behaviors and identify barriers to care. This collaboration highlights the importance of academic-industry partnerships in advancing public health research. I extend my sincere gratitude to Philip Morisky, MBA, Ξ and the adherence. for supporting non-funded studies like mine, paving the way for evidence-based interventions to improve patient outcomes. For researchers exploring medication adherence in diverse populations, I highly recommend exploring the MMAS-8 tools. Together, we can drive impactful research and contribute to better healthcare outcomes globally. ?? Here’s to advancing research, fostering collaboration, and making a difference! #MMAS8 #MedicationAdherence #BreastCancerResearch #PublicHealth #GlobalHealthResearch #Collaboration

Hello everyone! ??We want to remind you of the article on the Morisky Medication Adherence Scale (MMAS), written by our special guest, the MBA. Philip Morisky, is now available in our newsletter " El Pulso Regulatorio Farmacéutico ". This article details the evolution of the MMAS from its beginnings in university research to its current status as a global standard in the assessment of medication adherence. ?? Why read it? ??Digital Health Innovation: Discover how MMAS is transforming into dynamic solutions that improve patient care. ??Global Impact: Learn about its application in various intervention strategies around the world. Don't miss this opportunity to delve deeper into a topic so relevant to the health sector. You can access the full article by following this link: https://lnkd.in/e7GeDpx8 We hope you enjoy reading it as much as we enjoyed sharing it with you! Stay tuned for more exclusive content. #Innovación #SaludDigital #Adherenciaalamedicación #MMAS #Atenciónalpaciente #Tecnologíasanitaria #ESREG

?Hola a todos! ??Queremos recordarles que el artículo sobre la?Escala de Adherencia a la Medicación de Morisky (MMAS), escrito por nuestro invitado especial, el MBA. Philip Morisky, ya está disponible en nuestro boletín "El Pulso Regulatorio Farmacéutico". Este artículo detalla la evolución de la MMAS desde sus inicios en la investigación universitaria hasta su estatus actual como un estándar mundial en la evaluación de la adherencia a la medicación. ?? ?Por qué leerlo? ??Innovación en Salud Digital:?Descubra cómo la MMAS se está transformando en soluciones dinámicas que mejoran la atención al paciente. ??Impacto Global:?Aprende sobre su aplicación en diversas estrategias de intervención alrededor del mundo. No te pierdas esta oportunidad de profundizar en un tema tan relevante para el sector salud. Puedes acceder al artículo completo siguiendo este enlace:?Leer el artículo aquí?https://lnkd.in/e7GeDpx8 ?Esperamos que disfruten de la lectura tanto como nosotros disfrutamos compartiéndolo con ustedes! Mantente conectado para más contenido exclusivo. #Innovación #SaludDigital #Adherenciaalamedicación #MMAS #Atenciónalpaciente #Tecnologíasanitaria #ESREG

?? RPM and Adherence: Driving Better Patient Outcomes Together ???? In healthcare, #RPM (Remote Patient Monitoring) acts as an acceleration metric, keeping us on track with patient health in real time. But what about the why behind the numbers? That’s where the Morisky Medication Adherence Scale (#MMAS) comes in. Think of MMAS as the adherence metric that turns monitoring into managing. By integrating MMAS into RPM solutions—whether through EHRs or Chronic Care Management programs—we go beyond measuring vital signs. We unlock a deeper understanding of adherence behaviors, identifying roadblocks and enabling timely, targeted interventions. When we measure adherence, we can manage it. And when we manage it, we improve outcomes. With MMAS as a catalyst, RPM evolves into more than a method—it becomes a driver for better health. Let’s accelerate change, one patient at a time. ?? In 2025, the weight of medication adherence and other key measures will increase in the 2025 Medicare Advantage Star Ratings relative to 2024. This is because CAHPS measures will be?double-weighted instead of quadruple-weighted. Now more than ever, we need to optimize adherence strategies for better performance in Medicare Advantage plans.

?? RPM and Adherence: Driving Better Patient Outcomes Together ???? In healthcare, #RPM (Remote Patient Monitoring) acts as an acceleration metric, keeping us on track with patient health in real time. But what about the why behind the numbers? That’s where the Morisky Medication Adherence Scale (#MMAS) comes in. Think of MMAS as the adherence metric that turns monitoring into managing. By integrating MMAS into RPM solutions—whether through EHRs or Chronic Care Management programs—we go beyond measuring vital signs. We unlock a deeper understanding of adherence behaviors, identifying roadblocks and enabling timely, targeted interventions. When we measure adherence, we can manage it. And when we manage it, we improve outcomes. With MMAS as a catalyst, RPM evolves into more than a method—it becomes a driver for better health. Let’s accelerate change, one patient at a time. ?? Follow adherence. as we enter 2025 and the weight of medication adherence and other key measures will increase in the 2025 Medicare Advantage Star Ratings relative to 2024. This is because CAHPS measures will be?double-weighted instead of quadruple-weighted. Now more than ever, we need to optimize adherence strategies for better performance in Medicare Advantage plans.

Weekend insights ?? Transforming Schizophrenia Treatment: The Power of Long-Acting Injectables (LAIs) and a Team-Driven Approach ??We know that Schizophrenia care is evolving, and long-acting injectables (LAIs) are quickly becoming a game-changer in ensuring treatment consistency and improving outcomes. But innovation doesn’t stop at medication. A team-driven approach, collaborative care model; combining insights from psychiatrists, pharmacists, nurses, and behavioral health specialists, is just what the doctor ordered to address the multifaceted needs of patients. ????????????Collaboration across disciplines ensures a holistic care plan, from medication management to psychosocial support. Leveraging tools like the Morisky Medication Adherence Scale (#MMAS) as part of the intervention allows the team to measure and address adherence barriers proactively, helping patients stay on track with their treatment goals. A recent article by Dr. Tracy Hicks details how long-acting injectables (LAIs) are vital in managing schizophrenia, improving adherence, and reducing relapse and rehospitalization rates, yet stigma and misconceptions persist, often limiting their early use despite strong evidence supporting their benefits. A team-based, patient-centric approach that includes shared decision-making empowers patients, addresses barriers, and enhances outcomes, paving the way for more effective and compassionate schizophrenia care. What are your thoughts on integrating innovative tools and team-driven strategies in mental health care? Share below! Article is also posted in comments. Worth the read!